At Terumo Blood and Cell Technologies, we believe hope is concrete. Evidence-based. Real. It’s living within us all, thanks to the blood and cells flowing through every human body. We unlock the potential of blood and cells turning hope into reality.
A trauma victim fighting for survival. A child diagnosed with cancer. A patient with a debilitating illness.
For these individuals, their care teams and so many others in healthcare, the need for hope is always front and center. Yet it can feel intangible and just out of reach.
At Terumo Blood and Cell Technologies, we believe hope is concrete. Evidence-based. Real. And it’s living within us all, thanks to the blood and cells flowing through every human body.
From lifesaving blood transfusion to next-generation therapies, blood and cells are used daily as essential medicine in an extensive range of treatments throughout the world.
We are part of Terumo, a global company that has been contributing to society through healthcare for over 100 years. Headquartered in Japan, our name comes from our first innovation – the humble thermometer. Our division, Terumo Blood and Cell Technologies, began as a Colorado-based start-up 60 years ago, innovating around equipment that collects and processes our fragile, yet powerful, blood and cells.
Today, our portfolio has grown beyond equipment, providing data management, optimization services and clinical expertise to expand the application of transfusion medicine, and increase access to the foundational power of blood as an essential medicine. This includes expanding therapeutic applications of our current apheresis technology, enabling treatment of cancers with stem cell transplants, while shaping the source materials to fuel plasma-derived therapies and emerging cell therapies that address rare diseases.
From automated blood and cell processing systems to advanced cell collection techniques, our solutions enable better patient outcomes.
Collaboration amplifies our reach, expanding access to care — our ultimate goal. We partner with clinicians, advocacy groups and governments to break barriers and foster new business models. Where someone lives or who they are should not determine their quality of care.
At Terumo Blood and Cell Technologies, we believe the future of blood and cell-based therapies is rich with opportunities to change lives. Our job is — and always has been — to help transform ideas into real-world solutions that patients, and our customers and partners who serve them, can count on.
Together with healthcare systems around the world, we are unlocking the potential of blood and cells to turn hope into reality and do more for patients.
We are dedicated to making every drop of blood count.
Find out more about DAVOS 2025 Campaign
